About Odhav Pharma Guinee SAS
Odhav Pharma Guinee SAS began its commercial production in September 2024, emerging as one of the largest and most advanced pharmaceutical manufacturing facilities in West Africa. With state-of-the-art infrastructure and a strong commitment to quality, innovation, and accessibility, the company is dedicated to enhancing regional healthcare standards through world-class pharmaceutical solutions.
Key Production Capacities
Large Volume Parenterals
36.5 Million Bottles per Annum (LVP)
Tablets
730 Million Tablets per Annum
Syrups
14.6 Million Litres per Annum of Syrup
High-Volume, High-Quality Production
Odhav Pharma delivers life-saving medicines across West Africa with world-class facilities.
Pharmaceutical Production Overview
Odhav Pharma Guinee SAS plays a pivotal role in improving the availability of essential medicines, exporting its products to multiple neighboring countries while ensuring affordability, reliability, and compliance with international standards.
Odhav Pharma Guinee SAS
Guinee
- Production Stared 2024
- Production Capacity: 36.5 Million Bottles per Annum (LVP), 730 Million Tablets per Annum, 14.6 Million Litres per Annum of Syrup
- Employment Local : 500 no’s
- Expatriate : 100 no’s
- Pharma Product: Glucose, Syrup, Tablet
Certifications & Compliance
Showcasing our commitment to quality, safety, and global standards.
Quality Management System
Environmental Management System
Occupational Health & Safety Management System
